{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:48:40Z","timestamp":1772840920108,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute","award":["P50CA08393"],"award-info":[{"award-number":["P50CA08393"]}]},{"name":"Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema"},{"DOI":"10.13039\/100016591","name":"Heinz Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016591","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Olayan-Xefos Family Fund for Breast Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01050-z","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T18:02:15Z","timestamp":1680976935000},"page":"3671-3680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Side effects of COVID-19 vaccinations in patients treated for breast cancer"],"prefix":"10.1007","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct048727384","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Brooke C.","family":"Juhel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Brunelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison C.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda W.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazim S.","family":"Ababneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Hausman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loryn K.","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Naoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-9355","authenticated-orcid":false,"given":"Alphonse G.","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"issue":"7","key":"1050_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.acra.2022.02.015","volume":"29","author":"HL Chung","year":"2022","unstructured":"Chung HL, Whitman GJ, Leung JWT, Sun J, Middleton LP, Le-Petross HT. Ultrasound features to differentiate COVID-19 vaccine-induced benign adenopathy from breast cancer related malignant adenopathy. Acad Radiol. 2022;29(7):1004\u201312. https:\/\/doi.org\/10.1016\/j.acra.2022.02.015.","journal-title":"Acad Radiol."},{"key":"1050_CR2","unstructured":"Recurrent Breast Cancer. Mayo Clin. 2022; Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/recurrent-breast-cancer\/symptoms-causes\/syc-20377135"},{"issue":"3","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"584586","DOI":"10.2214\/AJR.21.25688","volume":"217","author":"CD Lehman","year":"2021","unstructured":"Lehman CD, Lamb LR, D\u2019Alessandro HA. Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach. Am J Roentgenol. 2021;217(3):584586.","journal-title":"Am J Roentgenol"},{"key":"1050_CR4","doi-asserted-by":"crossref","unstructured":"Tu W, Gierada DS, Joe BN. Covid-19 vaccination\u2013related lymphadenopathy: What to be aware of. Radiol Imaging Cancer. 2021;3(3).","DOI":"10.1148\/rycan.2021210038"},{"issue":"5","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"27","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"key":"1050_CR7","unstructured":"Centers for Disease Control and Prevention. Website. Pfizer-BioNTech COVID-19 Vaccine Reactions & Adverse Events. Last reviewed 06\/21\/2022. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html"},{"key":"1050_CR8","unstructured":"Center for Disease Control and Prevention. Website. The Moderna COVID-19 vaccine\u2019s local reactions, systemic reactions, adverse events, and serious adverse events. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html"},{"key":"1050_CR9","first-page":"417","volume-title":"Foldi\u2019s textbook of lymphology","author":"E Foldi","year":"2006","unstructured":"Foldi E, Foldi M. Foldi\u2019s textbook of lymphology. In: Foldi M, editor. Foldi\u2019s textbook of lymphology. Munich, Germany: Elsevier; 2006. p. 417\u201327."},{"issue":"6","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315.","journal-title":"Lancet Oncol"},{"issue":"7","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GKD, Scott-conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959\u201372.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1245\/s10434-012-2290-x","volume":"19","author":"JLB Bevilacqua","year":"2012","unstructured":"Bevilacqua JLB, Kattan MW, Changhong Y, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol. 2012;19(8):2580\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","volume":"88","author":"LEG Warren","year":"2014","unstructured":"Warren LEG, Miller CL, Horick N, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014 1;88(3):565\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"32","key":"1050_CR14","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-013-2715-7","volume":"142","author":"LS Jammallo","year":"2013","unstructured":"Jammallo LS, Miller CL, Singer M, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat. 2013;142(1):59\u201367.","journal-title":"Breast Cancer Res Treat"},{"issue":"29","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","volume":"38","author":"GE Naoum","year":"2020","unstructured":"Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599\u2013609.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","volume":"13","author":"LG Wilke","year":"2006","unstructured":"Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13(4):491\u2013500.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5306\/wjco.v5.i3.241","volume":"5","author":"MR Fu","year":"2014","unstructured":"Fu MR. Breast cancer-related lymphedema: symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014;5(3):241\u20137.","journal-title":"World J Clin Oncol"},{"issue":"9","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1016\/S1470-2045(16)30204-2","volume":"17","author":"MS Asdourian","year":"2016","unstructured":"Asdourian MS, Skolny MN, Brunelle C, Seward CE, Salama L, Taghian AG. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol. 2016;17(9):e392-405.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/ptj\/pzaa162","volume":"100","author":"CL Brunelle","year":"2020","unstructured":"Brunelle CL, Roberts SA, Horick NK, Gillespie TC, Jacobs JM, Daniell KM, Naoum GE, Taghian AG. Integrating symptoms into the diagnostic criteria for breast cancer\u2013related lymphedema: applying results from a prospective surveillance program. Phys Therapy. 2020;100(12):2186\u201397. https:\/\/doi.org\/10.1093\/ptj\/pzaa162.","journal-title":"Phys Therapy"},{"issue":"6","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00006199-200311000-00004","volume":"52","author":"JM Armer","year":"2003","unstructured":"Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370\u20139.","journal-title":"Nurs Res"},{"issue":"5","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1188\/14.ONF.473-483","volume":"41","author":"LS Jammallo","year":"2014","unstructured":"Jammallo LS, Miller CL, Horick NK, et al. Factors associated with fear of lymphedema after treatment for breast cancer. Oncol Nurs Forum. 2014;41(5):473\u201383.","journal-title":"Oncol Nurs Forum"},{"issue":"10","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","volume":"24","author":"SA McLaughlin","year":"2017","unstructured":"McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert Asbrs panel: part 1: definitions, assessments, education, and future directions. Ann Surg Oncol. 2017;24(10):2818\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12609-020-00376-x","volume":"12","author":"LH Eaton","year":"2020","unstructured":"Eaton LH, Narkthong N, Hulett JM. Psychosocial issues associated with breast cancer-related lymphedema: a literature review. Curr Breast Cancer Rep. 2020;12(4):216\u201324.","journal-title":"Curr Breast Cancer Rep"},{"key":"1050_CR26","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang H, Zhong Q et al. Predictors of quality of life in patients with breast cancer-related lymphedema: effect of age, lymphedema severity, and anxiety. Lymphat Res Biol. 2021","DOI":"10.1089\/lrb.2020.0073"},{"issue":"2","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/jpm5020153","volume":"5","author":"C Brunelle","year":"2015","unstructured":"Brunelle C, Skolny M, Ferguson C, Swaroop M, O\u2019Toole J, Taghian AG. Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the Massachusetts General Hospital: Lessons Learned. J Pers Med. 2015;5(2):153\u201364.","journal-title":"J Pers Med."},{"issue":"3","key":"1050_CR28","first-page":"1663","volume":"25","author":"SA Meo","year":"2021","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663\u201379.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/01.REO.0000000000000308","volume":"40","author":"S Wechsler","year":"2022","unstructured":"Wechsler S, Kneiss J, Adams B, Wood Magee LJ. Persistent cancer-related fatigue after breast cancer treatment predicts postural sway and postexertional changes in sit-to-stand strategy. Rehabil Oncol. 2022;40(4):162\u201371.","journal-title":"Rehabil Oncol"},{"key":"1050_CR30","unstructured":"Centers for Disease Control and Prevention. Website. Side Effects of Cancer Treatments. Last reviewed 06\/09\/2022. Available from: https:\/\/www.cdc.gov\/cancer\/survivors\/patients\/side-effects-of-treatment.htm"},{"issue":"3","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"E Montecino-rodriguez","year":"2013","unstructured":"Montecino-rodriguez E, Berent-maoz B, Dorshkind K, Montecino-rodriguez E, Berent-maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123(3):958\u201365.","journal-title":"J Clin Invest"},{"issue":"5","key":"1050_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1086\/590435","volume":"198","author":"JE McElhaney","year":"2008","unstructured":"McElhaney JE, Dutz JP. Better influenza vaccines for older people: What will it take? J Infect Dis. 2008;198(5):632\u20134.","journal-title":"J Infect Dis"},{"issue":"5","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwh227","volume":"160","author":"TA Reichert","year":"2004","unstructured":"Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959\u20131999. Am J Epidemiol. 2004;160(5):492\u2013502.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2005.04.018","volume":"23","author":"DM Fleming","year":"2005","unstructured":"Fleming DM, Elliot AJ. The impact of influenza on the health and health care utilisation of elderly people. Vaccine. 2005;23(1):S1\u20139.","journal-title":"Vaccine"},{"key":"1050_CR35","unstructured":"Wyant T, Alteri R, Kalidas M, Ogoro C, Lubejko B, Eidsmoe K. Why people with cancer are more likely to get infections. American Cancer Society. 2021. pp. 1\u201341."},{"issue":"23","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384(23):2187\u2013201.","journal-title":"N Engl J Med"},{"key":"1050_CR37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13524","author":"N Hiller","year":"2021","unstructured":"Hiller N, Goldberg SN, Cohen-Cymberknoh M, Vainstein V, Simanovsky N. Lymphadenopathy associated with the COVID-19 vaccine. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.13524.","journal-title":"Cureus"},{"key":"1050_CR38","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaoncol.2021.1962","volume":"7","author":"V-G Cynthia","year":"2021","unstructured":"Cynthia V-G, Vaca-Cartagena BF, Becerril-Gaitan A. Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol. 2021;7:1242.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1050_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.21.01891","volume":"40","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai V, Pernat CA, Gavralidis A, et al. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer: the CANVAX Cohort study. J Clin Oncol. 2022;40(1):12\u201323.","journal-title":"J Clin Oncol"},{"key":"1050_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","author":"C Herv\u00e9","year":"2019","unstructured":"Herv\u00e9 C, Laup\u00e8ze B, Del Giudice G, Didierlaurent AM, Da Silva FT. The how\u2019s and what\u2019s of vaccine reactogenicity. npj Vaccines. 2019. https:\/\/doi.org\/10.1038\/s41541-019-0132-6.","journal-title":"npj Vaccines"},{"key":"1050_CR41","unstructured":"Grimm L, Srini A, Dontchos B, et al. Revised SBI Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination Society of Breast Imaging Patient Care and Delivery Committee. 2022;(February):2020\u20133. Available from: https:\/\/www.sbi-online.org\/Portals\/0\/PositionStatements\/2021\/SBI-recommendations-for-"},{"key":"1050_CR42","volume-title":"Consensus document on COVID-19 vaccination for patients with lymphoedema","author":"PS Mortimer","year":"2021","unstructured":"Mortimer PS, Gordon K, Macallan D, et al. Consensus document on COVID-19 vaccination for patients with lymphoedema. UK: British Lymphology Society; 2021."},{"key":"1050_CR43","unstructured":"NLN Highlight on COVID-19 Vaccination Injection Site. National Lymphedema Network."},{"key":"1050_CR44","unstructured":"Caron C. Do I have to get the COVID vaccine in my arm? New York Times. 2021."},{"key":"1050_CR45","unstructured":"Wells J. Lymph node swelling and the COVID-19 vaccine. Mass General Giving. 2021."},{"key":"1050_CR46","unstructured":"Receiving the COVID-19 Vaccine After Cancer Surgery Requiring Lymph Node Removal Under the Arm. Mass General Cancer Center. 2021. Available from: https:\/\/www.massgeneral.org\/cancer-center\/news\/covid-19-vaccine-after-cancer-surgery-requiring-lymph-node-removal#:~:text=Lymph node swelling is a,to lymphedema after cancer treatment."},{"issue":"7","key":"1050_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1200\/JCO.2015.61.5948","volume":"34","author":"CM Ferguson","year":"2016","unstructured":"Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691\u20138.","journal-title":"J Clin Oncol"},{"key":"1050_CR48","unstructured":"Moderna COVID-19 Vaccine: Standing Orders for Administering Vaccine. 2022;10\u20133. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/downloads\/standing-orders.pdf"},{"key":"1050_CR49","unstructured":"Pfizer-BioNTech COVID-19 Vaccine: Standing Orders for Administering Vaccine. 2022;3\u20135. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/downloads\/standing-orders.pdf"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01050-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:12:13Z","timestamp":1698783133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01050-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01050-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alphonse G. Taghian has been loaned equipment from ImpediMed for use in an investigator-initiated clinical trial. Alphonse G. Taghian is on the Scientific Advisory Board of Puretech Health (not paid) and is a previous consultant for VisionRT. Both involvements are unrelated to this study. Cheryl L. Brunelle is on the Scientific Advisory Board of Puretech Health. The remaining authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Massachusetts General Hospital Institutional Review Board approved protocols 2021P000528 (COVID-19 vaccine survey) and 2021P003414 (secondary use protocol to analyze the vaccine survey in conjunction with breast cancer-related demographic and treatment factors). Consent was obtained electronically from participants prior to beginning the survey. The study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}